These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20015)

  • 1. The switch process in manic-depressive psychosis.
    Ann Intern Med; 1977 Sep; 87(3):319-35. PubMed ID: 20015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients.
    Berrettini WH; Nurnberger JI; Scheinin M; Seppala T; Linnoila M; Narrow W; Simmons-Alling S; Gershon ES
    Biol Psychiatry; 1985 Mar; 20(3):257-69. PubMed ID: 2579681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient.
    Post RM; Stoddard FJ; Gillin JC; Buchsbaum MS; Runkle DC; Black KE; Bunney WE
    Arch Gen Psychiatry; 1977 Apr; 34(4):470-7. PubMed ID: 192169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function.
    Swann AC; Stokes PE; Secunda SK; Maas JW; Bowden CL; Berman N; Koslow SH
    Biol Psychiatry; 1994 May; 35(10):803-13. PubMed ID: 7519061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites.
    Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
    Arch Gen Psychiatry; 1986 Oct; 43(10):1012-3. PubMed ID: 2428327
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients.
    Katz MM; Maas JW; Frazer A; Koslow SH; Bowden CL; Berman N; Swann AC; Stokes PE
    Neuropsychopharmacology; 1994 Oct; 11(2):89-100. PubMed ID: 7530963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome.
    Swann AC; Koslow SH; Katz MM; Maas JW; Javaid J; Secunda SK; Robins E
    Arch Gen Psychiatry; 1987 Apr; 44(4):345-54. PubMed ID: 2436590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S
    No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
    [No Abstract]   [Full Text] [Related]  

  • 12. Simulated behavior states: an approach to specificity in psychobiological research.
    Post RM; Goodwin FK
    Biol Psychiatry; 1973 Dec; 7(3):237-54. PubMed ID: 4357567
    [No Abstract]   [Full Text] [Related]  

  • 13. Biogenic amines and affective disorders.
    Schildkraut JJ
    Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
    [No Abstract]   [Full Text] [Related]  

  • 14. A dopaminergic mechanism in mania.
    Gerner RH; Post RM; Bunney WE
    Am J Psychiatry; 1976 Oct; 133(10):1177-80. PubMed ID: 970489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.
    Bunney WE; Goodwin FK; Murphy DL; House KM; Gordon EK
    Arch Gen Psychiatry; 1972 Sep; 27(3):304-9. PubMed ID: 4340658
    [No Abstract]   [Full Text] [Related]  

  • 16. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical and neuropharmacological aspects of depression.
    Leonard BE
    Int Rev Neurobiol; 1975; 18():357-87. PubMed ID: 1354
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of chronic alprazolam on sleep and bioamine metabolites in depression.
    Zarcone VP; Benson KL; Greene KA; Csernansky JG; Faull KF
    J Clin Psychopharmacol; 1994 Feb; 14(1):36-40. PubMed ID: 7512100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary adenosine 3',5'-monophosphate in the switch process from depression to mania.
    Paul MI; Cramer H; Bunney WE
    Science; 1971 Jan; 171(3968):300-3. PubMed ID: 4321392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.